Brazil
· Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 30.01 billion. The enterprise value is 37.84 billion.
| Market Cap | 30.01B |
| Enterprise Value | 37.84B |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
Raia Drogasil has 1.71 billion shares outstanding. The number of shares has decreased by -32.28% in one year.
| Current Share Class | 1.71B |
| Shares Outstanding | 1.71B |
| Shares Change (YoY) | -32.28% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 20.85% |
| Owned by Institutions (%) | 49.87% |
| Float | 838.41M |
Valuation Ratios
The trailing PE ratio is 19.32 and the forward PE ratio is 22.32. Raia Drogasil's PEG ratio is 1.45.
| PE Ratio | 19.32 |
| Forward PE | 22.32 |
| PS Ratio | 0.73 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 6.48 |
| P/FCF Ratio | 20.19 |
| P/OCF Ratio | 10.39 |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.59, with an EV/FCF ratio of 25.46.
| EV / Earnings | 30.93 |
| EV / Sales | 0.92 |
| EV / EBITDA | 8.59 |
| EV / EBIT | 15.98 |
| EV / FCF | 25.46 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.40 |
| Quick Ratio | 0.39 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 1.91 |
| Debt / FCF | 5.67 |
| Interest Coverage | 1.30 |
Financial Efficiency
Return on equity (ROE) is 19.22% and return on invested capital (ROIC) is 10.25%.
| Return on Equity (ROE) | 19.22% |
| Return on Assets (ROA) | 6.77% |
| Return on Invested Capital (ROIC) | 10.25% |
| Return on Capital Employed (ROCE) | 17.48% |
| Revenue Per Employee | 618,119 |
| Profits Per Employee | 18,459 |
| Employee Count | 64,758 |
| Asset Turnover | 1.87 |
| Inventory Turnover | 3.61 |
Taxes
In the past 12 months, Raia Drogasil has paid 85.94 million in taxes.
| Income Tax | 85.94M |
| Effective Tax Rate | 6.49% |
Stock Price Statistics
The stock price has decreased by -41.19% in the last 52 weeks. The beta is 0.08, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -41.19% |
| 50-Day Moving Average | 14.81 |
| 200-Day Moving Average | 19.10 |
| Relative Strength Index (RSI) | 69.50 |
| Average Volume (20 Days) | 11,765,275 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 40.97 billion and earned 1.22 billion in profits. Earnings per share was 0.91.
| Revenue | 40.97B |
| Gross Profit | 12.05B |
| Operating Income | 2.37B |
| Pretax Income | 1.32B |
| Net Income | 1.22B |
| EBITDA | 4.88B |
| EBIT | 2.37B |
| Earnings Per Share (EPS) | 0.91 |
Balance Sheet
The company has 605.30 million in cash and 8.42 billion in debt, giving a net cash position of -7.82 billion or -4.56 per share.
| Cash & Cash Equivalents | 605.30M |
| Total Debt | 8.42B |
| Net Cash | -7.82B |
| Net Cash Per Share | -4.56 |
| Equity (Book Value) | 6.69B |
| Book Value Per Share | 4.05 |
| Working Capital | 3.78B |
Cash Flow
In the last 12 months, operating cash flow was 2.89 billion and capital expenditures -1.40 billion, giving a free cash flow of 1.49 billion.
| Operating Cash Flow | 2.89B |
| Capital Expenditures | -1.40B |
| Free Cash Flow | 1.49B |
| FCF Per Share | 0.87 |
Margins
Gross margin is 29.41%, with operating and profit margins of 5.78% and 2.99%.
| Gross Margin | 29.41% |
| Operating Margin | 5.78% |
| Pretax Margin | 3.23% |
| Profit Margin | 2.99% |
| EBITDA Margin | 11.90% |
| EBIT Margin | 5.78% |
| FCF Margin | 3.63% |
Dividends & Yields
This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 2.32%.
| Dividend Per Share | 0.41 |
| Dividend Yield | 2.32% |
| Dividend Growth (YoY) | 40.48% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 44.58% |
| Buyback Yield | 32.28% |
| Shareholder Yield | 34.59% |
| Earnings Yield | 4.08% |
| FCF Yield | 4.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2023. It was a forward split with a ratio of 1.04.
| Last Split Date | May 22, 2023 |
| Split Type | Forward |
| Split Ratio | 1.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |